Activity of etoposide (VP-16) and teniposide (VM-26) in exponential and plateau phase human tumor cell cultures

Jean Chapuis, P. C. Keng, D. W. Siemann

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effects of etoposide (VP-16) and teniposide (VM-26) have been evaluated in human epidermoid carcinoma cells (A431, ME180 and HEp3) grown as exponential and plateau phase cultures. A significant increase in resistance to both these chemotherapeutic agents was observed in unfed plateau compared with exponential phase cells. The large differences in cell killing could not be explained by cell cycle specific toxicities resulting from variations in the cell cycle distributions. Rather the differences in the treatment efficacies probably reflect the 5- to 15-fold increase in the proportion of quiescent cells measured in the plateau phase cultures. These findings suggest that non-proliferating cells in tumors may be preferentially spared in treatments utilizing VP-16 and VM-26.

Original languageEnglish (US)
Pages (from-to)245-252
Number of pages8
JournalAnti-Cancer Drugs
Volume3
Issue number3
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Teniposide
Etoposide
Cell Culture Techniques
Neoplasms
Cell Cycle
Squamous Cell Carcinoma

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

Cite this

Activity of etoposide (VP-16) and teniposide (VM-26) in exponential and plateau phase human tumor cell cultures. / Chapuis, Jean; Keng, P. C.; Siemann, D. W.

In: Anti-Cancer Drugs, Vol. 3, No. 3, 01.01.1992, p. 245-252.

Research output: Contribution to journalArticle

@article{9a4fdbdc25654d70aa4a584bffbf7504,
title = "Activity of etoposide (VP-16) and teniposide (VM-26) in exponential and plateau phase human tumor cell cultures",
abstract = "The effects of etoposide (VP-16) and teniposide (VM-26) have been evaluated in human epidermoid carcinoma cells (A431, ME180 and HEp3) grown as exponential and plateau phase cultures. A significant increase in resistance to both these chemotherapeutic agents was observed in unfed plateau compared with exponential phase cells. The large differences in cell killing could not be explained by cell cycle specific toxicities resulting from variations in the cell cycle distributions. Rather the differences in the treatment efficacies probably reflect the 5- to 15-fold increase in the proportion of quiescent cells measured in the plateau phase cultures. These findings suggest that non-proliferating cells in tumors may be preferentially spared in treatments utilizing VP-16 and VM-26.",
author = "Jean Chapuis and Keng, {P. C.} and Siemann, {D. W.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1097/00001813-199206000-00007",
language = "English (US)",
volume = "3",
pages = "245--252",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Activity of etoposide (VP-16) and teniposide (VM-26) in exponential and plateau phase human tumor cell cultures

AU - Chapuis, Jean

AU - Keng, P. C.

AU - Siemann, D. W.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The effects of etoposide (VP-16) and teniposide (VM-26) have been evaluated in human epidermoid carcinoma cells (A431, ME180 and HEp3) grown as exponential and plateau phase cultures. A significant increase in resistance to both these chemotherapeutic agents was observed in unfed plateau compared with exponential phase cells. The large differences in cell killing could not be explained by cell cycle specific toxicities resulting from variations in the cell cycle distributions. Rather the differences in the treatment efficacies probably reflect the 5- to 15-fold increase in the proportion of quiescent cells measured in the plateau phase cultures. These findings suggest that non-proliferating cells in tumors may be preferentially spared in treatments utilizing VP-16 and VM-26.

AB - The effects of etoposide (VP-16) and teniposide (VM-26) have been evaluated in human epidermoid carcinoma cells (A431, ME180 and HEp3) grown as exponential and plateau phase cultures. A significant increase in resistance to both these chemotherapeutic agents was observed in unfed plateau compared with exponential phase cells. The large differences in cell killing could not be explained by cell cycle specific toxicities resulting from variations in the cell cycle distributions. Rather the differences in the treatment efficacies probably reflect the 5- to 15-fold increase in the proportion of quiescent cells measured in the plateau phase cultures. These findings suggest that non-proliferating cells in tumors may be preferentially spared in treatments utilizing VP-16 and VM-26.

UR - http://www.scopus.com/inward/record.url?scp=0026649437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026649437&partnerID=8YFLogxK

U2 - 10.1097/00001813-199206000-00007

DO - 10.1097/00001813-199206000-00007

M3 - Article

VL - 3

SP - 245

EP - 252

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 3

ER -